CD8A and COVID-19: We analyzed HLA-A*24:02-positive PBMCs from individuals who recovered from COVID-19 (n = 3) and healthy individuals without any evident SARS-CoV-2 infection (n = 3) to examine CD8+ T cells that might recognize MHC class I-binding peptides we identified.